[go: up one dir, main page]

HK1114784A1 - 脑膜炎联合疫苗 - Google Patents

脑膜炎联合疫苗 Download PDF

Info

Publication number
HK1114784A1
HK1114784A1 HK08110172.1A HK08110172A HK1114784A1 HK 1114784 A1 HK1114784 A1 HK 1114784A1 HK 08110172 A HK08110172 A HK 08110172A HK 1114784 A1 HK1114784 A1 HK 1114784A1
Authority
HK
Hong Kong
Prior art keywords
composition
serogroup
saccharide
conjugated
antigen
Prior art date
Application number
HK08110172.1A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1114784B (zh
Inventor
Mario Contorni
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34424891&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1114784(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0323102A external-priority patent/GB0323102D0/en
Priority claimed from GB0412052A external-priority patent/GB0412052D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1114784A1 publication Critical patent/HK1114784A1/zh
Publication of HK1114784B publication Critical patent/HK1114784B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6068Other bacterial proteins, e.g. OMP
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
HK08110172.1A 2003-10-02 2008-09-12 脑膜炎联合疫苗 HK1114784B (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0323102A GB0323102D0 (en) 2003-10-02 2003-10-02 Liquid vaccines for multiple meningococcal serogroups
GB0323102 2003-10-02
GB0412052A GB0412052D0 (en) 2004-05-28 2004-05-28 Liquid vaccines for multiple meningococcal serogroups
GB0412052 2004-05-28

Publications (2)

Publication Number Publication Date
HK1114784A1 true HK1114784A1 (zh) 2008-11-14
HK1114784B HK1114784B (zh) 2011-12-16

Family

ID=

Also Published As

Publication number Publication date
US20080241180A1 (en) 2008-10-02
EP1961426B1 (en) 2011-04-27
US9180204B2 (en) 2015-11-10
PT1961426E (pt) 2011-06-28
HK1087946A1 (zh) 2006-10-27
RU2009134033A (ru) 2011-03-20
CA2540896A1 (en) 2005-04-14
BR122017002991B1 (pt) 2023-01-10
CN103405761A (zh) 2013-11-27
EP1670506A2 (en) 2006-06-21
RU2378010C2 (ru) 2010-01-10
US8765135B2 (en) 2014-07-01
PT1670506E (pt) 2013-01-28
RU2006114677A (ru) 2007-11-10
JP2007507487A (ja) 2007-03-29
US20150004191A1 (en) 2015-01-01
WO2005032583A3 (en) 2006-03-23
CY1113888T1 (el) 2016-07-27
PL1961426T3 (pl) 2012-03-30
RU2595845C2 (ru) 2016-08-27
PL1670506T3 (pl) 2013-04-30
JP2014196362A (ja) 2014-10-16
NZ546430A (en) 2009-04-30
JP4738339B2 (ja) 2011-08-03
EP1961426A1 (en) 2008-08-27
AU2004277758A1 (en) 2005-04-14
DK1670506T3 (da) 2013-02-25
WO2005032583A2 (en) 2005-04-14
AU2009200203A1 (en) 2009-02-12
CN103357002A (zh) 2013-10-23
DK1961426T3 (da) 2011-08-08
EP1670506B1 (en) 2012-11-21
JP5618842B2 (ja) 2014-11-05
EP2277538A1 (en) 2011-01-26
ATE506963T1 (de) 2011-05-15
DE602004032481D1 (de) 2011-06-09
ES2397923T3 (es) 2013-03-12
SI1961426T1 (sl) 2011-10-28
BRPI0415025A (pt) 2006-12-12
SI1670506T1 (sl) 2013-03-29
CA2885040A1 (en) 2005-04-14
JP2011068698A (ja) 2011-04-07
CA2540896C (en) 2015-06-02
CA2885040C (en) 2018-10-30
CY1113522T1 (el) 2016-06-22

Similar Documents

Publication Publication Date Title
EP1961426B1 (en) Combined meningitis vaccines
EP2351579B1 (en) Polypeptide vaccines for broad protection against hypervirulent meningococcal lineages
EP2191844A1 (en) Injectable vaccines against multiple meningococcal serogroups
ES2363182T3 (es) Vacunas combinadas contra la meningitis.
AU2014265019B2 (en) Liquid vaccines for multiple meningococcal serogroups
CN1764472B (zh) 抗多种脑膜炎球菌血清组的可注射性疫苗
HK1114784B (zh) 脑膜炎联合疫苗
HK1152643A (zh) 联合脑膜炎疫苗
HK1087946B (zh) 用於多种脑膜炎球菌血清型的液体疫苗
MXPA06003728A (es) Vacunas liquidas para multiples serogrupos meningococales

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20161004